Positive IND-enabling data on MP0712 targeting DLL3, the most advanced Radio-DARPin program in co-development with Orano Med, entering clinical development in 2025 First preclinical data of novel ...

The full schedule and registration details can be found at gotoper.com.

For these UC students, hands-on research has led to class credit, money for school and a path to their dream future.

Tad Eastman, a 60-year-old artist battling stage four prostate cancer, is showcasing his life's work in a York gallery. When you visit an art gallery, you'd expect for each piece of art each to tell a ...

AI is increasingly influencing the fields of art and design opening up new possibilities, and challenges, for artists and ...

Researchers in Nikolaus Rajewsky's lab at Max Delbrück Center combined high-resolution, single-cell spatial technologies to map a tumor's cellular neighborhoods in 3D and identify potential targets ...

BOSTON, MA, UNITED STATES, April 24, 2025 /EINPresswire.com/ -- Affini-T Therapeutics to present data from pipeline programs targeting the cancer driver mutations KRAS G12V and TP53 R175H.

The American Lung Association has revealed that nearly half the U.S. population resided in areas with dangerous levels of air ...

Incidence rate for prostate cancer has been increasing since 2014 at a rate of 3% per year overall BOSTON, MA, UNITED STATES, ...

1. Compared to receiving intravenous (directly into a vein (IV)) anti-cancer therapy in hospital outpatient clinics, we are uncertain whether receiving the same therapy at home affects the management ...

A “loving and affectionate” mum-of-six died the day after she was supposed to start cancer treatment. Heidi Lock, from ...